Active, not recruiting Obesity Drug: Retatrutide Drug: Tirzepatide A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight (TRIUMPH-2) The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have o
The Bigger Picture Ozempic, Wegovy, Mounjaro, and Zepbound are not replacing your DMARDs or your biologics
Summary Keywords drug-repositioning, thyroid-cancer, anti-diabetic, metformin, diabetes Citation Greco A, Coperchini F, Croce L, Magri F, Teliti M and Rotondi M (2023) Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs
You can consider body composition measurement every few months if it is accessible and if the method is consistent
Biomedicines (2022) 10(11):35
4 Endothelial dysfunction as a central mechanism in cardiovascular disease: molecular insights ED plays a central role in the pathogenesis and progression of CVD, including atherosclerosis, hypertension, HF, stroke, and peripheral artery disease
